📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

EML4-ALK biology and drug resistance in non-small cell lung cancer: a new phase of discoveries. (2023)

First Author: Elshatlawy M
Attributed to:  Understanding and targeting oncogenic biomolecular condensates of ALK kinase funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/1878-0261.13446

PubMed Identifier: 37149843

Publication URI: http://europepmc.org/abstract/MED/37149843

Type: Journal Article/Review

Volume: 17

Parent Publication: Molecular oncology

Issue: 6

ISSN: 1574-7891